Amcor

End‑market exposure skews to food, beverage, pharma and personal care, creating recurring volumes and relatively stable cash generation through cycles. The enlarged portfolio diversifies by customer and region, while synergy schedules and published outlooks add visibility.

FY26 guidance calls for 12 to 17 percent EPS growth and FCF roughly doubling versus FY25, driven largely by self‑help rather than an aggressive macro recovery assumption. Predictability is above average for a manufacturer, though not at the level of payment networks or data monopolies.